Sulfonylurea Pharmacotherapy Regimen Adherence in a Medicaid Population: Influence of Age, Gender, and Race

No abstract is available for this paper.

• Publication year

  1999

• Venue

  The diabetes educator

• Publication date

  1999-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1177/014572179902500406PMID 10614258
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of troglitazone in insulin-treated patients with type II diabetes mellitus. Troglitazone and Exogenous Insulin Study Group.

  1998cited by this paper
• Economic Consequences of Diabetes Mellitus in the U.S. in 1997

  1998cited by this paper
• Prevalence of Diabetes, Impaired Fasting Glucose, and Impaired Glucose Tolerance in U.S. Adults: The Third National Health and Nutrition Examination Survey, 1988–1994

  1998cited by this paper
• Pharmacological regulation of blood glucose levels in non-insulin-dependent diabetes mellitus.

  1997cited by this paper
• Drug Treatment of Non-Insulin-Dependent Diabetes Mellitus in the 1990s

  1997cited by this paper
• A Stable Isotope Dilution Assay for the In Vivo Determination of Insulin Levels in Humans by Mass Spectrometry

  1997cited by this paper
• Brain damage in divers

  1997cited by this paper
• Long-Term Treatment of Type 2 Diabetic Patients with the New Oral Antidiabetic Agent Glimepiride (Amaryl®): A Double-Blind Comparison with Glibenclamide

  1996cited by this paper
• Pharmacologic treatment options for non-insulin-dependent diabetes mellitus.

  1996cited by this paper
• Assessment of Sulfonylurea Adherence and Metabolic Control

  1995cited by this paper
• Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group.

  1995cited by this paper
• Efficacy of 24-Week Monotnerapy With Acarbose, Glibenclamide, or Placebo in NIDDM Patients: The Essen Study

  1994cited by this paper
• Effects of the Carbohydrase Inhibitor Miglitol in Sulfonylurea-Treated NIDDM Patients

  1994cited by this paper
• The management of non-insulin-dependent diabetes mellitus in the elderly.

  1993cited by this paper
• Effect of value–added utilities on prescription refill compliance and Medicaid health care expenditures–a study of patients with non–insulin–dependent diabetes mellitus

  1993cited by this paper
• Medication compliance: the patient's perspective.

  1993cited by this paper
• Medication compliance: the patient's perspective.

  1993cited by this paper
• Impact of Community-Based Diabetes Education on Program Attenders and Nonattenders

  1992cited by this paper
• Sulfonylureas in NIDDM

  1992cited by this paper
• Evaluating the Costs and Benefits of Outpatient Diabetes Education and Nutrition Counseling

  1986cited by this paper
• Glipizide: A Second‐generation Sulfonylurea Hypoglycemic Agent; Pharmacology, Pharmacokinetics and Clinical Use

  1985cited by this paper
• Glyburide: A Second‐generation Sulfonylurea Hypoglycemic Agent

  1985cited by this paper
• Recurrent Use of Disposable Syringe-Needle Units in Diabetic Children

  1984cited by this paper
• Glyburide and glipizide, second-generation oral sulfonylurea hypoglycemic agents.

  1984cited by this paper
• Non-insulin-dependent diabetes mellitus: a clinical strategy.

  1984cited by this paper

• Is There a Role for Diabetes Stewardship in Orthopaedics? Observations From a Hand and Upper Extremity Surgery Clinic.

  2025cites this paper
• Coping with diabetes: Provider attributes that influence type 2 diabetes adherence

  2019cites this paper
• Determinants and Effects of Medication Beliefs in Chronic Illness

  2019cites this paper
• Type 2 diabetes: Challenges facing GPs

  2018cites this paper
• A randomized controlled trial on the effect of behavioral strategies for adherence to oral antidiabetic drugs: study protocol

  2017cites this paper
• Review on Comparison of Diabetic Patient Adherence to Anti-diabetic Medication (Oral Hypoglycemic Agents vs Injectable Insulin)

  2017cites this paper
• Compliance and Treatment Failure of Hepatitis C with Direct-acting Antivirals: A 2-Year Retrospective, Observational Study in Kentucky Medicaid Patients

  2017cites this paper
• Patterns of Adherence to Oral Hypoglycemic Agents and Glucose Control among Primary Care Patients with Type 2 Diabetes

  2016cites this paper
• Adherence to oral hypoglycemic agents: Patterns, correlates and outcomes

  2014cites this paper
• Clinical outcomes and incremental costs from a medication adherence pilot intervention targeting low-income patients with diabetes at risk of cost-related medication nonadherence.

  2014cites this paper
• Evaluating the role of hypoglycemia & comorbid illness on diabetes management behaviors

  2014cites this paper
• Evaluation of the relationship between Body Mass Index (BMI) and healthcare cost, utilization and health-related quality of life in adult diabetic patients

  2014cites this paper
• Advantages and limitations of the new anticoagulants

  2014cites this paper
• Adherence to anti-diabetic drugs among patients with Type 2 diabetes mellitus at Muhimbili National Hospital, Dar es Salaam, Tanzania- A cross-sectional study

  2014cites this paper
• How to use pharmacy claims data to measure patient nonadherence? The example of oral diabetics in therapy of type 2 diabetes mellitus

  2013cites this paper
• Retrospective real-world adherence in patients with type 2 diabetes initiating once-daily liraglutide 1.8 mg or twice-daily exenatide 10 μg.

  2013cites this paper
• Medication adherence program: adherence challenges and interventions in type 2 diabetes.

  2013cites this paper
• Assessement of the level of knowledge, self care practice and glycemic control among patients with type 2 diabetes

  2013cites this paper
• Adherence to anticoagulant treatment with dabigatran in a real‐world setting

  2013cites this paper
• 50% adherence of patients suffering chronic conditions – where is the evidence?

  2012cites this paper
• Patient and Physician Factors Associated With Adherence to Diabetes Medications

  2012cites this paper
• Correlates of Medication Nonadherence Among Latinos With Type 2 Diabetes

  2012cites this paper
• Pharmacoepidemiological profiles of oral hypoglycemic agents among 28,773 Chinese patients with diabetes.

  2012cites this paper
• Anforderungen an ein effektives Adherence-Persistence-Programm am Beispiel von oralen Anti-diabetika bei Diabetes mellitus Typ 2-Patienten Requirements of an Effective Adherence-Persistence Program Using the Example of Oral Diabetics for Diabetes Mellitus Type 2 Patients

  2011cites this paper
• Regional, Geographic, and Ethnic Differences in Medication Adherence among Adults with Type 2 Diabetes

  2011cites this paper
• Racial and Ethnic Differences in Cardiovascular Disease Medication Management for Patients with Diabetes

  2010cites this paper
• The need for oral antidiabetic treatment adherence studies in the pediatric population.

  2010cites this paper
• Adherence to Cardiovascular Disease Medications: Does Patient-Provider Race/Ethnicity and Language Concordance Matter?

  2010cites this paper
• Factors associated with medication adherence to oral hypoglycaemic agents in different ethnic groups suffering from Type 2 diabetes: a systematic literature review and suggestions for further research

  2010cites this paper
• Measuring Persistence to Oral Hypoglycemic Agents in Type 2 Diabetic Veterans

  2009cites this paper
• Predictors and Impact of Intensification of Antihyperglycemic Therapy in Type 2 Diabetes

  2009cites this paper
• Predictors and Impact of Intensification of Antihyperglycemic Therapy in T ype 2 Diabetes Translating Research into Action for Diabetes (TRIAD)

  2009cites this paper
• Barriers to Medication Adherence in Poorly Controlled Diabetes Mellitus

  2008cites this paper
• Medicaid Payment Systems: Impact On Quality Of Care, Medication Adherence And Healthcare Service Utilizations In Type 2 Diabetes Medicaid Enrollees

  2008cites this paper
• Why Don’t Diabetes Patients Achieve Recommended Risk Factor Targets? Poor Adherence versus Lack of Treatment Intensification

  2008cites this paper
• Impact of dose frequency on compliance and health outcomes: a literature review (1966–2006)

  2007cites this paper
• Drug Class Review on Fixed Dose Combination Drug Products for the Treatment of Type 2 Diabetes and Hyperlipidemia

  2007cites this paper
• Medication Taking and Diabetes

  2007cites this paper
• Racial differences in oral antidiabetic medication adherence, healthcare utilization and costs associated with type 2 diabetes in medicaid enrollees

  2006cites this paper
• Comparison of medication adherence and associated health care costs after introduction of pioglitazone treatment in African Americans versus all other races in patients with type 2 diabetes mellitus: a retrospective data analysis.

  2006cites this paper
• Caring for Poorly Controlled Diabetes Mellitus: A Randomized Pharmacist Intervention

  2005cites this paper
• Adherence with pharmacotherapy for type 2 diabetes: a retrospective cohort study of adults with employer-sponsored health insurance.

  2005cites this paper
• Using pharmacy claims data to evaluate adherence and persistence with prescribed medications in patients with diabetes mellitus

  2004cites this paper
• A Systematic Review of Adherence With Medications for Diabetes

  2004cites this paper
• A systematic review of adherence with medications for diabetes.

  2004cites this paper
• Adherence to oral therapy for type 2 diabetes: opportunities for enhancing glycemic control.

  2004cites this paper
• Diabetes care today: not everyone should have intensive multipharmacological treatment

  2004cites this paper
• Nonadherence as a predictor of antidiabetic drug therapy intensification (augmentation)

  2004influential citation
• Diabetes care today: not everyone should have intensive multipharmacological treatment.

  2004cites this paper
• Inconsistent use of diabetes medications, diabetes complications, and mortality in older mexican americans over a 7-year period: data from the Hispanic established population for the epidemiologic study of the elderly.

  2003cites this paper
• Racial differences in adherence to cardiac medications.

  2003cites this paper
• Addressing Dosing Frequency in Diabetes: A Simple Approach to Improving Adherence to Therapy and Clinical Outcomes

  2003cites this paper
• Refill compliance in type 2 diabetes mellitus: a predictor of switching to insulin therapy?

  2003cites this paper
• Adherence to oral hypoglycaemic agents prior to insulin therapy in Type 2 diabetes

  2002cites this paper
• Persistence Patterns with Oral Hypoglycemic Agents in Type 2 Diabetes

  2002influential citation
• Type 2 diabetes mellitus treatment strategies in primary care: Utrecht Diabetes Epidemiology Studies

  2002cites this paper
• Hypoglycemic drug utilization and adherence to prescribed regimens: A pharmacoepidemiologic study using retail pharmacy data

  2001cites this paper
• Time use in clinical encounters: are African-American patients treated differently?

  2001cites this paper
• Primary care Randomised controlled trial of structured personal care of type 2 diabetes mellitus

  year unknowncites this paper